Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2019-07-20
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Phenylketonuria-type Diet on Appetite, Appetite Hormones and Diet Induced Thermogenesis
NCT02440932
The Effect of a Natural Extract on Glucose Fluxes After Consumption of a Wheat Product
NCT02662738
Sweetened Beverages and Food Intake
NCT00475475
Effect Dietary Fructose on Fructose Kinetics in Type 2 Diabetes
NCT05717608
Reducing Free Sugar Intakes: A Role for Sweet Taste
NCT05684757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group starting intervention with vegetable protein
Phase A followed by Phases B, C, D, E.
Phase B - Extra 1 Phe exchange from fruits/vegetables containing Phe from 76-100mg/100g
Usual low Phe diet + 60g fruits/vegetables containing Phe from 76-100mg/100g
Phase C - Extra 2 Phe exchanges from fruits/vegetables containing Phe from 76-100mg/100g
Usual low Phe diet + 120g fruits/vegetables containing Phe from 76-100mg/100g
Phase D - Extra 1 Phe exchange from milk or yoghurt
Usual low Phe diet but 1 x 50 mg extra Phe exchange from milk or yoghurt
Phase E - Extra 2 Phe exchanges from milk or yoghurt
Usual low Phe diet but 2 x 50 mg extra Phe exchange from milk or yoghurt eaten daily
Group starting intervention with animal protein
Phase A followed by Phases D, E, B, C.
Phase B - Extra 1 Phe exchange from fruits/vegetables containing Phe from 76-100mg/100g
Usual low Phe diet + 60g fruits/vegetables containing Phe from 76-100mg/100g
Phase C - Extra 2 Phe exchanges from fruits/vegetables containing Phe from 76-100mg/100g
Usual low Phe diet + 120g fruits/vegetables containing Phe from 76-100mg/100g
Phase D - Extra 1 Phe exchange from milk or yoghurt
Usual low Phe diet but 1 x 50 mg extra Phe exchange from milk or yoghurt
Phase E - Extra 2 Phe exchanges from milk or yoghurt
Usual low Phe diet but 2 x 50 mg extra Phe exchange from milk or yoghurt eaten daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phase B - Extra 1 Phe exchange from fruits/vegetables containing Phe from 76-100mg/100g
Usual low Phe diet + 60g fruits/vegetables containing Phe from 76-100mg/100g
Phase C - Extra 2 Phe exchanges from fruits/vegetables containing Phe from 76-100mg/100g
Usual low Phe diet + 120g fruits/vegetables containing Phe from 76-100mg/100g
Phase D - Extra 1 Phe exchange from milk or yoghurt
Usual low Phe diet but 1 x 50 mg extra Phe exchange from milk or yoghurt
Phase E - Extra 2 Phe exchanges from milk or yoghurt
Usual low Phe diet but 2 x 50 mg extra Phe exchange from milk or yoghurt eaten daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Early and continuously treated;
* Adherent to their prescribed PKU diet consisting of a protein-restricted diet and Phe-free amino acid based protein substitute;
* In good general health as evidenced by medical history;
* Able to provide written informed consent/assent (parent/child);
* Able to comply with the study protocol and take study product according to the opinion of the PI;
* Patients with good metabolic control (age 5-12y, 120-360μmol/L) with 3 out of 4 levels within range prior to consent (if 2 of 4 above target range but one close to the upper limit, PI to decide if patient can enter the study).
Exclusion Criteria
* Dislikes fruits and vegetables containing 76-100 mg of Phe/100g e.g.brocolli or cauliflower;
* Treated with BH4 (sapropterin);
* Presence of intercurrent infection;
* Patients with poor metabolic control (age 5-12y, \>360μmol/L).
5 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alex Pinto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alex Pinto
Research Dietitian
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham Women's and Children's Hospital
Birmingham, West Midlands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18/BC/DTS/NO/215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.